Variant · Snv
RET NM_020975.6(RET):c.1154G>T (p.Gly385Val)
CI-VAR-00097049Explore in graph →p.Gly385ValNM_020975.6:c.1154G>TClinVar 543752 rs906695652
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 543752 | Uncertain significance | criteria provided, multiple submitters, no conflicts | 2 | Multiple endocrine neoplasia, type 2; Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2B; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2A; Pheochromocytoma; Hereditary cancer-predisposing syndrome | germline | 3 | Jan 24, 2024 | clinvar |